Chongqing Beibei R&D Site
Here is the headquarters of Porton. The R&D center is designed to provide customers with DS and DP R&D services.
No.7, Yuntu Road, Beibei District, Chongqing, 400714, China
2005Founded
Major departments include the Small Molecule Process Development Department, the Analytical Development Department, the Kilogram Laboratory, as well as Safety Laboratory and High Potent Lab. We have a technical platform for SFC.
9Buildings
We have 20+ labs and ~200 chemists, more than half of whom have postgraduate degrees.We continue to provide excellent CRO services.
20,000m2Area
The R&D center has passed world wide TOP 20 big pharma EHS audits.
Capabilities
Major departments include the Small Molecule Process Development Department, the Analytical Development Department, the Kilogram Laboratory, as well as Safety Laboratory and High Potent Lab. We have a technical platform for SFC.
Services
Small Molecule
Small Molecule
Porton offers efficient, flexible, and high-quality solutions for custom development and production of small molecule APIs, as well as technical services throughout the entire lifecycle from pre-clinical to commercial stages to our worldwide partners.
One Porton One Quality
Compliance standards, Continuous improvement, Customer oriented
Quality management runs throughout the entire process of the drug life cycle. The quality management system of the drug product site is built in accordance with international standards and continues to adhere to the quality concept of 'more well-established system, more controllable quality.' This ensures that the GMP activities of the drug product site meet the requirements of international quality management systems and market drug regulatory agencies, including those of China, the European Union, FDA, and other mainstream regulations.
Case Studies
Preformulation Strategy- Inception to Completion
Facilitating PROTAC Drugs Development with Innovative Processes
Continuous Improvement of Project Life Cycle Management, Benefiting Customers by Reducing Total Cost
Agile and Fast：Enabling Rapid Market Launch of Innovative Drugs from Preclinical to Commercialization in 18 Months
